{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:47:00Z","timestamp":1790729220594,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013500","name":"Canadian Cardiovascular Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000238","name":"Brain Tumour Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218426","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:10Z","timestamp":1773215110000},"page":"218426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploiting metabolic dependencies for therapeutic targeting of brain cancers"],"prefix":"10.1016","volume":"646","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3985-0703","authenticated-orcid":false,"given":"Emma","family":"Martell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Kuzmychova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaljot","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218426_bib1","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib2","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/d41586-018-06704-7","article-title":"Breaking down the epidemiology of brain cancer","volume":"561","author":"Gould","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218426_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-019-1158-7","article-title":"Childhood cerebellar tumours mirror conserved fetal transcriptional programs","volume":"572","author":"Vladoiu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nor040","article-title":"International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors","volume":"13","author":"Lassman","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Genome atlas research, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib9","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/2159-8290.CD-12-0426","article-title":"Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN","volume":"3","author":"Bjerke","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218426_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2026.218426_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","article-title":"Medulloblastoma","volume":"5","author":"Northcott","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218426_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.devcel.2025.10.018","article-title":"Medulloblastoma stem cell programs: molecular roadmaps of disease progression","volume":"61","author":"Zagozewski","year":"2026","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218426_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218426_bib19","first-page":"157","article-title":"Wasserstoff\u00fcbertragendes Co-Ferment, seine Zusammensetzung und Wirkungsweise","volume":"282","author":"Otto","year":"1935","journal-title":"Biochem. Z."},{"key":"10.1016\/j.canlet.2026.218426_bib20","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1038\/s41388-025-03429-6","article-title":"Functional mitochondrial respiration is essential for glioblastoma tumour growth","volume":"44","author":"Brisudova","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218426_bib21","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41467-023-38049-9","article-title":"Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma","volume":"14","author":"Martell","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.cell.2020.04.047","article-title":"Metabolic regulation of the epigenome drives lethal infantile ependymoma","volume":"181","author":"Michealraj","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218426_bib24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/neuonc\/now024","article-title":"Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation","volume":"18","author":"Kathagen-Buhmann","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-025-09460-7","article-title":"Rewiring of cortical glucose metabolism fuels human brain cancer growth","volume":"646","author":"Scott","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib26","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1158\/1078-0432.CCR-15-2274","article-title":"Myc-driven glycolysis is a therapeutic target in glioblastoma","volume":"22","author":"Tateishi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218426_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000677","article-title":"Metabolic modulation of glioblastoma with dichloroacetate","volume":"2","author":"Michelakis","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10637-013-0047-4","article-title":"Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors","volume":"32","author":"Dunbar","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2026.218426_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fonc.2019.00993","article-title":"Dimethylaminomicheliolide (DMAMCL) suppresses the proliferation of glioblastoma cells via targeting pyruvate kinase 2 (PKM2) and rewiring aerobic glycolysis","volume":"9","author":"Guo","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib31","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic state of glioma stem cells and nontumorigenic cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218426_bib32","doi-asserted-by":"crossref","first-page":"32843","DOI":"10.1074\/jbc.M111.260935","article-title":"Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis","volume":"286","author":"Zhou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218426_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/nn.3510","article-title":"Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake","volume":"16","author":"Flavahan","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2026.218426_bib34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ccell.2017.10.016","article-title":"Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma","volume":"32","author":"Cosset","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","article-title":"Proteomic tumor analysis, proteogenomic and metabolomic characterization of human glioblastoma","volume":"39","author":"Wang","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s43018-020-00159-4","article-title":"Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities","volume":"2","author":"Garofano","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218426_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40478-023-01604-y","article-title":"Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations","volume":"11","author":"Martell","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib38","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s42255-020-00313-3","article-title":"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers","volume":"2","author":"Lin","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.canlet.2026.218426_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1669565","article-title":"Recent progress in serine metabolism reprogramming in tumors and strategies for serine deprivation","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib40","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/s41388-024-03122-0","article-title":"The methionine cycle and its cancer implications","volume":"43","author":"Tassinari","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218426_bib41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41419-018-0997-8","article-title":"Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells","volume":"9","author":"Sharif","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218426_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-020-01114-1","article-title":"Glioma cells require one-carbon metabolism to survive glutamine starvation","volume":"9","author":"Tanaka","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-012-1018-x","article-title":"Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1","volume":"111","author":"Liu","year":"2013","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib44","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41416-020-0794-x","article-title":"Serine-dependent redox homeostasis regulates glioblastoma cell survival","volume":"122","author":"Engel","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218426_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.1218099","article-title":"A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans","volume":"337","author":"Bricker","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218426_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cmet.2019.11.002","article-title":"Regulation of tumor initiation by the mitochondrial pyruvate carrier","volume":"31","author":"Bensard","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218426_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s42255-018-0002-y","article-title":"Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer","volume":"1","author":"Bader","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.canlet.2026.218426_bib49","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/neuonc\/noaf008","article-title":"Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma","volume":"27","author":"Martell","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","article-title":"Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver","volume":"29","author":"Cappel","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218426_bib51","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1016627108","article-title":"Pyruvate carboxylase is required for glutamine-independent growth of tumor cells","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218426_bib52","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/neuonc\/noae106","article-title":"Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target","volume":"26","author":"Renoult","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Martinez-Reyes","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib55","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-Mutant low-grade glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib58","article-title":"Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: tolerability, predictors of response, and outcomes","volume":"7","author":"Lanman","year":"2025","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.canlet.2026.218426_bib59","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ccell.2025.04.013","article-title":"Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis","volume":"43","author":"Dang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib60","article-title":"Metformin and risk of malignant brain tumors in patients with type 2 diabetes mellitus","volume":"11","author":"Tseng","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218426_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ijc.31783","article-title":"Use of metformin and survival of patients with high-grade glioma","volume":"144","author":"Seliger","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218426_bib62","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.32337","article-title":"Use of metformin and outcome of patients with newly diagnosed glioblastoma: pooled analysis","volume":"146","author":"Seliger","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218426_bib63","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00018-007-7080-4","article-title":"Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis","volume":"64","author":"Isakovic","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2026.218426_bib64","doi-asserted-by":"crossref","first-page":"56456","DOI":"10.18632\/oncotarget.10919","article-title":"Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218426_bib65","doi-asserted-by":"crossref","first-page":"78787","DOI":"10.18632\/oncotarget.12859","article-title":"Metformin treatment reduces temozolomide resistance of glioblastoma cells","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218426_bib66","doi-asserted-by":"crossref","first-page":"32930","DOI":"10.18632\/oncotarget.5405","article-title":"Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218426_bib67","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41591-020-0985-2","article-title":"Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin","volume":"26","author":"Ayoub","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","article-title":"Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma","volume":"567","author":"Shi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib69","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib70","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib71","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1074\/jbc.RA120.013366","article-title":"IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism","volume":"295","author":"Tsuji","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218426_bib72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218426_bib74","article-title":"The role of glutamate and glutamine metabolism and related transporters in nerve cells","volume":"30","author":"Zhang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.canlet.2026.218426_bib75","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-19-3923","article-title":"Brain tumor stem cell dependence on glutaminase reveals a metabolic vulnerability through the amino acid deprivation response pathway","volume":"80","author":"Restall","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218426_bib76","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1158\/1078-0432.CCR-16-3102","article-title":"Efficient mitochondrial glutamine targeting prevails over glioblastoma metabolic plasticity","volume":"23","author":"Oizel","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218426_bib77","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/jnen\/nlab018","article-title":"Novel glutamine antagonist JHU395 suppresses MYC-driven medulloblastoma growth and induces apoptosis","volume":"80","author":"Pham","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.canlet.2026.218426_bib78","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/nbm.2794","article-title":"Metabolism of [U-13 C]glucose in human brain tumors in vivo","volume":"25","author":"Maher","year":"2012","journal-title":"NMR Biomed."},{"key":"10.1016\/j.canlet.2026.218426_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12121280","article-title":"Lipid alterations in glioma: a systematic review","volume":"12","author":"Abdul Rashid","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.canlet.2026.218426_bib80","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41467-022-29137-3","article-title":"Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ccell.2025.12.012","article-title":"Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastoma","volume":"44","author":"Bernardi","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6288","article-title":"Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models","volume":"15","author":"Eyme","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218426_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050688","article-title":"Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides","volume":"11","author":"Villa","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218426_bib84","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218426_bib85","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ccell.2022.07.012","article-title":"A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma","volume":"40","author":"Pal","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2022.07.011","article-title":"De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib87","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ccell.2022.10.009","article-title":"Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma","volume":"40","author":"Gwynne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib88","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","article-title":"Purine metabolism regulates DNA repair and therapy resistance in glioblastoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218426_bib89","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.2015","article-title":"Results from phase 1 study of mycophenolate mofetil with chemoradiation in newly diagnosed glioblastoma to target de-novo purine metabolism to overcome treatment resistance","volume":"43","author":"Umemura","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218426_bib90","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.trecan.2024.08.005","article-title":"Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes","volume":"10","author":"Gantner","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218426_bib91","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218426_bib92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218426_bib93","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib94","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","article-title":"The role of protein lactylation: a kaleidoscopic post-translational modification in cancer","volume":"85","author":"Iozzo","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218426_bib95","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","article-title":"AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases","volume":"634","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218426_bib96","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","article-title":"ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion","volume":"37","author":"Zhu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218426_bib97","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cmet.2024.11.005","article-title":"Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218426_bib98","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chembiol.2019.11.005","article-title":"Non-enzymatic lysine lactoylation of glycolytic enzymes","volume":"27","author":"Gaffney","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218426_bib99","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218426_bib100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176851","article-title":"Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Investig."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:38:57Z","timestamp":1776857937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":100,"alternative-id":["S0304383526001898"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218426","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting metabolic dependencies for therapeutic targeting of brain cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218426"}}